カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

パーキンソン病治療薬の世界市場2022：臨床用、実験用

■ 英語タイトル：Global Parkinsons Disease Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3884）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3884
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[パーキンソン病治療薬の世界市場2022：臨床用、実験用]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のパーキンソン病治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のパーキンソン病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

パーキンソン病治療薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・臨床用、実験用

アプリケーション別セグメントは次のように区分されます。
・治療、予防

世界のパーキンソン病治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、パーキンソン病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパーキンソン病治療薬メーカーの企業概要、2019年～2022年までのパーキンソン病治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパーキンソン病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別パーキンソン病治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのパーキンソン病治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパーキンソン病治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびパーキンソン病治療薬の産業チェーンを掲載しています。
・第13、14、15章では、パーキンソン病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– パーキンソン病治療薬の概要
– 種類別分析（2017年vs2021年vs2028年）：臨床用、実験用
– 用途別分析（2017年vs2021年vs2028年）：治療、予防
– 世界のパーキンソン病治療薬市場規模・予測
– 世界のパーキンソン病治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：臨床用、実験用
・用途別分析2017年-2028年：治療、予防
・パーキンソン病治療薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パーキンソン病治療薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パーキンソン病治療薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パーキンソン病治療薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・パーキンソン病治療薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Parkinsons Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinsons Disease Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Clinical
1.2.3 Experiment
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinsons Disease Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treament
1.3.3 Prevention
1.4 Global Parkinsons Disease Drugs Market Size & Forecast
1.4.1 Global Parkinsons Disease Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Parkinsons Disease Drugs Sales in Volume (2017-2028)
1.4.3 Global Parkinsons Disease Drugs Price (2017-2028)
1.5 Global Parkinsons Disease Drugs Production Capacity Analysis
1.5.1 Global Parkinsons Disease Drugs Total Production Capacity (2017-2028)
1.5.2 Global Parkinsons Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinsons Disease Drugs Market Drivers
1.6.2 Parkinsons Disease Drugs Market Restraints
1.6.3 Parkinsons Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Parkinsons Disease Drugs Product and Services
2.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Parkinsons Disease Drugs Product and Services
2.2.4 Gilead Sciences Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Parkinsons Disease Drugs Product and Services
2.3.4 Pacira Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Product and Services
2.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Parkinsons Disease Drugs Product and Services
2.5.4 Luye Pharma Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Parkinsons Disease Drugs Product and Services
2.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Product and Services
2.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Product and Services
2.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Parkinsons Disease Drugs Product and Services
2.9.4 CSPC Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Parkinsons Disease Drugs Product and Services
2.10.4 Novartis Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Parkinsons Disease Drugs Product and Services
2.11.4 Kingond Pharm Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Parkinsons Disease Drugs Breakdown Data by Manufacturer
3.1 Global Parkinsons Disease Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Parkinsons Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Parkinsons Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Parkinsons Disease Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Parkinsons Disease Drugs Manufacturer Market Share in 2021
3.5 Global Parkinsons Disease Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Parkinsons Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parkinsons Disease Drugs Market Size by Region
4.1.1 Global Parkinsons Disease Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Parkinsons Disease Drugs Revenue by Region (2017-2028)
4.2 North America Parkinsons Disease Drugs Revenue (2017-2028)
4.3 Europe Parkinsons Disease Drugs Revenue (2017-2028)
4.4 Asia-Pacific Parkinsons Disease Drugs Revenue (2017-2028)
4.5 South America Parkinsons Disease Drugs Revenue (2017-2028)
4.6 Middle East and Africa Parkinsons Disease Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Parkinsons Disease Drugs Sales in Volume by Type (2017-2028)
5.2 Global Parkinsons Disease Drugs Revenue by Type (2017-2028)
5.3 Global Parkinsons Disease Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Parkinsons Disease Drugs Sales in Volume by Application (2017-2028)
6.2 Global Parkinsons Disease Drugs Revenue by Application (2017-2028)
6.3 Global Parkinsons Disease Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Parkinsons Disease Drugs Sales by Type (2017-2028)
7.2 North America Parkinsons Disease Drugs Sales by Application (2017-2028)
7.3 North America Parkinsons Disease Drugs Market Size by Country
7.3.1 North America Parkinsons Disease Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Parkinsons Disease Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Parkinsons Disease Drugs Sales by Type (2017-2028)
8.2 Europe Parkinsons Disease Drugs Sales by Application (2017-2028)
8.3 Europe Parkinsons Disease Drugs Market Size by Country
8.3.1 Europe Parkinsons Disease Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Parkinsons Disease Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Parkinsons Disease Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Parkinsons Disease Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Parkinsons Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Parkinsons Disease Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Parkinsons Disease Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Parkinsons Disease Drugs Sales by Type (2017-2028)
10.2 South America Parkinsons Disease Drugs Sales by Application (2017-2028)
10.3 South America Parkinsons Disease Drugs Market Size by Country
10.3.1 South America Parkinsons Disease Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Parkinsons Disease Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parkinsons Disease Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Parkinsons Disease Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Parkinsons Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Parkinsons Disease Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Parkinsons Disease Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Parkinsons Disease Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Parkinsons Disease Drugs
12.3 Parkinsons Disease Drugs Production Process
12.4 Parkinsons Disease Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Parkinsons Disease Drugs Typical Distributors
13.3 Parkinsons Disease Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Parkinsons Disease Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Parkinsons Disease Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Parkinsons Disease Drugs Product and Services
Table 6. Johnson & Johnson Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Sciences Major Business
Table 9. Gilead Sciences Parkinsons Disease Drugs Product and Services
Table 10. Gilead Sciences Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pacira Basic Information, Manufacturing Base and Competitors
Table 12. Pacira Major Business
Table 13. Pacira Parkinsons Disease Drugs Product and Services
Table 14. Pacira Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharmaceutical Major Business
Table 17. Sun Pharmaceutical Parkinsons Disease Drugs Product and Services
Table 18. Sun Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Luye Pharma Major Business
Table 21. Luye Pharma Parkinsons Disease Drugs Product and Services
Table 22. Luye Pharma Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sigma-Tau Group Basic Information, Manufacturing Base and Competitors
Table 24. Sigma-Tau Group Major Business
Table 25. Sigma-Tau Group Parkinsons Disease Drugs Product and Services
Table 26. Sigma-Tau Group Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 28. Fudan-Zhangjiang Major Business
Table 29. Fudan-Zhangjiang Parkinsons Disease Drugs Product and Services
Table 30. Fudan-Zhangjiang Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Major Business
Table 33. Teva Pharmaceutical Parkinsons Disease Drugs Product and Services
Table 34. Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. CSPC Basic Information, Manufacturing Base and Competitors
Table 36. CSPC Major Business
Table 37. CSPC Parkinsons Disease Drugs Product and Services
Table 38. CSPC Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Parkinsons Disease Drugs Product and Services
Table 42. Novartis Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Kingond Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Kingond Pharm Major Business
Table 45. Kingond Pharm Parkinsons Disease Drugs Product and Services
Table 46. Kingond Pharm Parkinsons Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Parkinsons Disease Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Parkinsons Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Parkinsons Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Parkinsons Disease Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Parkinsons Disease Drugs Production Site of Key Manufacturer
Table 52. Parkinsons Disease Drugs New Entrant and Capacity Expansion Plans
Table 53. Parkinsons Disease Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Parkinsons Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 55. Global Parkinsons Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 56. Global Parkinsons Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Parkinsons Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Global Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Global Parkinsons Disease Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Parkinsons Disease Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Parkinsons Disease Drugs Price by Type (2017-2022) & (USD/Unit)
Table 63. Global Parkinsons Disease Drugs Price by Type (2023-2028) & (USD/Unit)
Table 64. Global Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Global Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Global Parkinsons Disease Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Parkinsons Disease Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Parkinsons Disease Drugs Price by Application (2017-2022) & (USD/Unit)
Table 69. Global Parkinsons Disease Drugs Price by Application (2023-2028) & (USD/Unit)
Table 70. North America Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 71. North America Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 72. North America Parkinsons Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Parkinsons Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 75. North America Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 76. North America Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 77. North America Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Europe Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 79. Europe Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 80. Europe Parkinsons Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Parkinsons Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Europe Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Europe Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Europe Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Parkinsons Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Parkinsons Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Parkinsons Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Parkinsons Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 94. South America Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 95. South America Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 96. South America Parkinsons Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Parkinsons Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 99. South America Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 100. South America Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 101. South America Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Parkinsons Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Parkinsons Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Parkinsons Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Parkinsons Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Parkinsons Disease Drugs Raw Material
Table 111. Key Manufacturers of Parkinsons Disease Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Parkinsons Disease Drugs Typical Distributors
Table 115. Parkinsons Disease Drugs Typical Customers
List of Figures
Figure 1. Parkinsons Disease Drugs Picture
Figure 2. Global Parkinsons Disease Drugs Revenue Market Share by Type in 2021
Figure 3. Clinical
Figure 4. Experiment
Figure 5. Global Parkinsons Disease Drugs Revenue Market Share by Application in 2021
Figure 6. Treament
Figure 7. Prevention
Figure 8. Global Parkinsons Disease Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Parkinsons Disease Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Parkinsons Disease Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Parkinsons Disease Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Parkinsons Disease Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Parkinsons Disease Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Parkinsons Disease Drugs Market Drivers
Figure 15. Parkinsons Disease Drugs Market Restraints
Figure 16. Parkinsons Disease Drugs Market Trends
Figure 17. Global Parkinsons Disease Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Parkinsons Disease Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Parkinsons Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Parkinsons Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Parkinsons Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Parkinsons Disease Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Parkinsons Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Parkinsons Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Parkinsons Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Parkinsons Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Parkinsons Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Parkinsons Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Parkinsons Disease Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Parkinsons Disease Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Parkinsons Disease Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Parkinsons Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Parkinsons Disease Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Parkinsons Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Parkinsons Disease Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Parkinsons Disease Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Parkinsons Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Parkinsons Disease Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Parkinsons Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Parkinsons Disease Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Parkinsons Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Parkinsons Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Parkinsons Disease Drugs in 2021
Figure 76. Manufacturing Process Analysis of Parkinsons Disease Drugs
Figure 77. Parkinsons Disease Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • パーキンソン病治療薬のグローバル市場展望 2023年-2029年：臨床、実験
  • パーキンソン病用薬剤のグローバル市場展望 2023年-2029年：カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害剤
  • 糖代謝異常症治療薬の世界市場2022：OTC、Rxドラッグ
  • 脂質代謝疾患治療薬の世界市場2022：OTC、Rxドラッグ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3884 )"パーキンソン病治療薬の世界市場2022：臨床用、実験用" (英文：Global Parkinsons Disease Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。